Ligand Pharmaceuticals
LGND
LGND
184 hedge funds and large institutions have $1.4B invested in Ligand Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 69 increasing their positions, 62 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
11% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 62
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
184
Holding in Top 10
6
Calls
$23.7M
Puts
$21.3M
Top Buyers
| 1 | +$21M | |
| 2 | +$20.5M | |
| 3 | +$19.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$7.25M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$7.18M |
Top Sellers
| 1 | -$35.6M | |
| 2 | -$17.4M | |
| 3 | -$13M | |
| 4 |
ACMM
Arbor Capital Management (Minnesota)
Minneapolis,
Minnesota
|
-$7.99M |
| 5 |
GP
Grow Partners
San Diego,
California
|
-$7.92M |